XT
CRBP icon

XTX Topco’s Corbus Pharmaceuticals CRBP Stock Holding History

XTX Topco’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$635K Buy
67,654
+29,631
+78% +$281K 0.01% 2231
2026
Q1 		$357K Buy
+38,023
New +$320K 0.01% 2333
2024
Q2 		– Sell
-10,290
Closed -$404K – 1964
2024
Q1 		$404K Buy
+10,290
New +$254K 0.05% 617
2022
Q1 		– Sell
-1,149
Closed -$21K – 713
2021
Q4 		$21K Sell
1,149
-238
-17% -$6.45K 0.01% 625
2021
Q3 		$42K Buy
+1,387
New +$54.7K 0.01% 612

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

XTX Topco's CRBP Position: Q2 2026 in Review

XTX Topco increased its Corbus Pharmaceuticals (CRBP) stake by 78% in Q2 2026, buying an estimated $281K and bringing the position to 67,654 shares worth $635K. The position accounts for 0.01% of the portfolio, ranked #2231.

XTX Topco first reported a position in CRBP in Q3 2021 and has held it in 5 quarters since. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • XTX Topco held 67,654 shares of Corbus Pharmaceuticals worth $635K as of Q2 2026.
  • XTX Topco bought 29,631 Corbus Pharmaceuticals shares in Q2 2026, an estimated $281K.
  • Corbus Pharmaceuticals made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2231 holding.
  • XTX Topco first reported a position in Corbus Pharmaceuticals in Q3 2021 and has held it in 5 quarters since.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.